@misc{indiciae6ebfb0830de8,
  title = {Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers},
  author = {Khan, H. Y. and Nagasaka, M. and Aboukameel, A. and Alkhalili, O. and Uddin, M. H. and Bannoura, S. and Mzannar, Y. and Ibrahim, A. and Beal, E. and Tobon, M. and Kim, S. and Beydoun, R. and Baloglu, E. and Senapedis, W. and Elrayes, B. and Philip, P. A. and Mohammad, R. M. and Shields, A. F. and Al-Hallak, M. N. and Azmi, A. S.},
  year = {2023},
  doi = {10.1101/2023.03.27.534309},
  url = {https://www.biorxiv.org/content/10.1101/2023.03.27.534309v1},
  note = {Source identifier: 10.1101/2023.03.27.534309}
}